PMID: 11905603Mar 22, 2002Paper

Melanoma-stroma interactions: structural and functional aspects

The Lancet Oncology
Dirk J RuiterM Herlyn

Abstract

Cutaneous melanomas are notorious for their tendency to metastasise. Because the tumour microenvironment plays an important part in tumour development and progression, we review the structural and functional aspects of interactions between melanoma and the stroma. We emphasise fibrovascular patterns (both in uveal and cutaneous melanoma), cellular and extracellular composition of the stroma, and the molecules involved. Also, we discuss functional interactions, focusing on melanoma-fibroblast cross-talk by soluble factors and by direct cell-cell contact. On the basis of recent findings we propose that involvement of fibroblasts in melanoma-stromagenesis occurs through different stages: recruitment, activation, and conversion to myofibroblasts, or differentiation to fibrocytes. We reason that this involvement is topographically linked to different areas in and around the tumour, and hypothesise that stromal activation, as seen in tumor ulceration or immunological regression in melanoma, stimulates tumour progression.

References

Jan 1, 1985·Virchows Archiv. A, Pathological Anatomy and Histopathology·S SutinenJ Tienari
Nov 1, 1995·Journal of the National Cancer Institute·I J Fidler
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M J ScanlanW J Rettig
Apr 1, 1994·Pigment Cell Research·M Herlyn, I M Shih
Jul 1, 1994·Scientific American·R K Jain
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K ForsbergB Westermark
Jul 1, 1996·Pathology, Research and Practice·G Gabbiani
Mar 1, 1997·The British Journal of Ophthalmology·A J FossS Lightman
Jul 3, 1997·International Journal of Cancer. Journal International Du Cancer·P A AndreasenM J Duffy
Jan 1, 1997·Ultrasound in Medicine & Biology·R H SilvermanD J Coleman
Apr 16, 1998·The British Journal of Ophthalmology·V Rummelt, G O Naumann
Jun 6, 1998·Science·K W Kinzler, B Vogelstein
Jul 1, 1998·International Reviews of Immunology·E Tartour, W H Fridman
Nov 18, 1998·Current Opinion in Cell Biology·N Boudreau, M J Bissell
Jan 5, 1999·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·M Bar-Eli
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·K TakahashiK K Tanabe
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K DanøL R Lund
Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Jan 5, 2000·The Journal of Clinical Investigation·S Rafii
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 10, 2000·The American Journal of Pathology·D M McDonaldR K Jain
Mar 31, 2000·Molecular Medicine Today·G Li, M Herlyn
May 3, 2000·Histopathology·S S Banerjee, M Harris
Jul 25, 2000·Molecular Medicine Today·C C ParkM H Barcellos-Hoff
Oct 21, 2000·Human Reproduction·L A SalamonsenL Lathbury
Feb 13, 2001·Current Biology : CB·L J McCawley, L M Matrisian
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Mar 10, 2001·The American Journal of Pathology·C BerkingM Herlyn
Mar 22, 2002·The Lancet Oncology·D J RuiterR M de Waal
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·C P EvansC G J Sweep

❮ Previous
Next ❯

Citations

Jan 3, 2006·Journal of Biosciences·Edna Cukierman
Jul 28, 2005·Archives of Dermatological Research·Uta B HofmannJürgen C Becker
Sep 25, 2008·Clinical & Experimental Metastasis·Janine T Erler, Valerie M Weaver
Aug 16, 2012·Clinical & Experimental Metastasis·Stanley P L LeongJohn M Kirkwood
Aug 19, 2008·Current Oncology Reports·Jessie Villanueva, Meenhard Herlyn
Mar 23, 2005·Biochimie·Uta B HofmannJürgen C Becker
Mar 24, 2004·Critical Reviews in Oncology/hematology·Anne-Laure LabroussePhilippe Bernard
May 20, 2004·Experimental Cell Research·Boris VuillermozYanusz Wegrowski
Nov 10, 2011·Molecular Pharmaceutics·Edward H FlachAlexander R A Anderson
Aug 17, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ossama AbbasMeera Mahalingam
Dec 21, 2002·Differentiation; Research in Biological Diversity·Mei-Yu HsuMeenhard Herlyn
May 15, 2012·The Journal of Biological Chemistry·Christian V RecktenwaldBarbara Seliger
Aug 13, 2008·Tissue Engineering. Part a·Marcos Perez-BasterrecheaJesus Otero
Jul 21, 2005·Nucleic Acids Research·Felix Naef, Joerg Huelsken
Oct 30, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jiping ZhangJonathan D Cheng
Jun 23, 2009·The American Journal of Dermatopathology·Denisa KacerovskaDmitry V Kazakov
May 20, 2011·Pigment Cell & Melanoma Research·Solange LandrevilleSylvain L Guérin
Jun 27, 2007·Investigative Ophthalmology & Visual Science·Robert FolbergAndrew J Maniotis
Dec 8, 2011·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J Humberto Treviño-VillarrealRick A Rogers
Jan 7, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jasper WoutersJoost J van den Oord
Aug 10, 2002·Seminars in Oncology·Dirk J RuiterUNKNOWN Pathology Committee of the European Organization Research and Treatment of Cancer (EORTC) Melanoma Group
Aug 13, 2011·Cellular and Molecular Life Sciences : CMLS·Katherine Biron-Pain, Yves St-Pierre
Mar 10, 2016·Indian Dermatology Online Journal·Kara Melissa T TorresDirk M Elston
Feb 5, 2013·Biochemical Pharmacology·Kim H T Paraiso, Keiran S M Smalley
Feb 13, 2013·Experimental Cell Research·Vivien J Coulson-ThomasHelena B Nader
Oct 28, 2011·Journal of the American Academy of Dermatology·Yevgeniy BalagulaAshfaq A Marghoob
Apr 17, 2009·American Journal of Clinical Pathology·Thilo GambichlerAlexander Kreuter
Oct 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Renzo Emanuel VeraNatalia Belén Rumie Vittar
Aug 18, 2009·Biomaterials·Shahram GhanaatiC James Kirkpatrick
Mar 11, 2004·The Journal of Investigative Dermatology·Monika GniadeckaHans Christian Wulf

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Reviews in Oncology/hematology
Anne-Laure LabroussePhilippe Bernard
Differentiation; Research in Biological Diversity
Mei-Yu HsuM Herlyn
Frontiers in Bioscience : a Journal and Virtual Library
Léon C L van KempenDirk J Ruiter
© 2022 Meta ULC. All rights reserved